AstraZeneca Plc revenue for the last year amounted to 45.81 B USD, the most of which — 17.56 B USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 14.37 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought AstraZeneca Plc 18.56 B USD, and the year before that — 16.96 B USD.